Timely antibiotics cut mortality in drug-resistant bacterial infections.
Timely appropriate antibiotics are crucial for managing multidrug-resistant Gram-negative bloodstream infections, yet their impact remains uncertain. Early best available therapy reduced 14-day mortality in 3rd-generation cephalosporin-resistant Enterobacterales infections by 7.4%, but results were unclear for carbapenem-resistant strains. The study suggests benefits of early appropriate therapy in certain infections, highlighting the need for optimized antimicrobial strategies particularly with high resistance settings. Early best available therapy reduces mortality in some multidrug-resistant Gram-negative bloodstream infections but may not suffice for all cases.
Authors: Mezzadri L, Tan WC, Hao X, Quah J, Manesh A, Chang YT, Nguyen ATK, Ding Y, Kitsaran S, Chua HH, Bory S, Ponnampalavanar S, Anunnatsiri S, Mazlan MZ, Dhiloo AK, Plongla R, Lay-Hoon Kwa A, Mahmood SF, Roman AD, Thwaites CL, Tho PV, Wu S, Chotiprasitsakul D, Wong KJ, Wijaya H, Abad CL, Rehman Khalid MO, Salahuddin Mamun GM, Rajahram GS, Gutierres H, Hon HN, Van Giang T, Pham NT, Karkey A, Gunasekara S, Hamers RL, Sinto R, Lubis IND, Wang M, Moni M, Liu PY, Xiao Y, Khanal B, Priya NL, Doi Y, Honda H, Baljin B, Gurav U, Asli R, Ling L, Dhungana A, Hsu LY, Paterson DL, Mo Y, ACORN-HAI investigators
Citation: Mezzadri L, Tan WC, Hao X, et al. Early best available antibiotic therapy for multidrug-resistant gram-negative bloodstream infections: a target trial emulation. EClinicalMedicine. 2026;101:104302. doi:10.1016/j.eclinm.2026.104302
Article Links: PubMed · Journal / DOI · Free Full Text (PMC)
One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.